Department of, Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India.
Department of, Pathology, All India Institute of Medical Sciences, New Delhi, India.
Clin Exp Dermatol. 2020 Mar;45(2):172-179. doi: 10.1111/ced.14061. Epub 2019 Sep 26.
Noncultured extracted hair follicle outer root sheath cell suspension (NC-EHF-ORS-CS) is an upcoming surgical technique to treat stable vitiligo. Conventionally it employs trypsin to tap the hair follicle (HF) reservoir for autologous melanocytes and their precursors for transplantation. However, a perifollicular dermal sheath composed of type 1 collagen encases the target 'bulge' region of the HF. Adding collagenase type 1 would digest the ORS, facilitating better release of cells.
To compare the repigmentation achieved using trypsin and a combination of collagenase plus trypsin, respectively, with dermabrasion alone, and to compare cell counts, viability and composition of both suspensions.
This was a randomized, double-blind, comparative, therapeutic trial, conducted as a pilot study on 22 patients with stable vitiligo. Three similar patches were randomized into three parallel treatment arms [(A) trypsin plus collagenase, (B) trypsin alone and (C) dermabrasion with vehicle alone]. Each patient's HF sample was divided and digested by the two methods, and transplanted as suspensions onto dermabraded patches, while a third dermabraded patch received the vehicle only. Suspensions were sent for laboratory analysis. Repigmentation was assessed over a follow-up of 6 months.
There was a significant increase in cell yield and comparable viability when collagenase was added. Immunohistochemical and flow cytometry studies showed a nonsignificant increase in HMB45+ melanocytes and their precursor stem cells in group A. This trend was reflected clinically in the extent of repigmentation [group A (33.22%) > B (24.31%) > C (16.59%); P = 0.13]. Adding collagenase induced significantly higher repigmentation than dermabrasion alone (P < 0.05).
Incorporating collagenase type I into the conventional NC-EHF-ORS-CS technique resulted in enhanced retrieval of pigment-forming cells and subsequently improved repigmentation in vitiligo.
未培养提取的毛囊外根鞘细胞悬液(NC-EHF-ORS-CS)是一种新兴的治疗稳定型白癜风的手术技术。传统上,它采用胰蛋白酶从毛囊(HF)库中提取自体黑色素细胞及其前体细胞进行移植。然而,一个由 1 型胶原组成的毛囊周围真皮鞘包围着 HF 的目标“隆起”区域。添加胶原酶 1 会消化 ORS,从而更方便地释放细胞。
分别比较用胰蛋白酶和胶原酶加胰蛋白酶组合处理与单独使用磨皮相比所达到的复色效果,并比较两种悬浮液的细胞计数、活力和组成。
这是一项随机、双盲、对照、治疗性试验,作为一项初步研究,在 22 名稳定型白癜风患者中进行。将三个相似的斑块随机分为三个平行的治疗组 [(A) 胰蛋白酶加胶原酶,(B) 胰蛋白酶单独使用,(C) 磨皮加载体单独使用]。每个患者的 HF 样本都被两种方法进行分割和消化,并作为悬浮液移植到磨皮的斑块上,而第三个磨皮的斑块则只接受载体。悬浮液被送到实验室进行分析。在 6 个月的随访期间评估复色情况。
添加胶原酶可显著增加细胞产量和相似的活力。免疫组织化学和流式细胞术研究表明,组 A 中 HMB45+黑色素细胞及其前体细胞干细胞的数量略有增加。这种趋势在临床上反映在复色的程度上[组 A(33.22%)>B(24.31%)>C(16.59%);P=0.13]。与单独磨皮相比,添加胶原酶可显著提高复色效果(P<0.05)。
将 I 型胶原酶纳入常规 NC-EHF-ORS-CS 技术可增强色素形成细胞的提取,从而改善白癜风的复色效果。